An in vivo RNAi screen identifies SALL1 as a tumor suppressor in human breast cancer with a role in CDH1 regulation

J. Wolf, K. Müller-Decker, C. Flechtenmacher, F. Zhang, M. Shahmoradgoli, Gordon Mills, J. D. Hoheisel, M. Boettcher

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The gold standard for determining the tumorigenic potential of human cancer cells is a xenotransplantation into immunodeficient mice. Higher tumorigenicity of cells is associated with earlier tumor onset. Here, we used xenotransplantation to assess the tumorigenic potential of human breast cancer cells following RNA interference-mediated inhibition of over 5000 genes. We identify 16 candidate tumor suppressors, one of which is the zinc-finger transcription factor SALL1. Analyzing this particular molecule in more detail, we show that inhibition of SALL1 correlates with reduced levels of CDH1, an important contributor to epithelial-to-mesenchymal transition. Furthermore, SALL1 expression led to an increased migration and more than twice as many cells expressing a cancer stem cell signature. Also, SALL1 expression correlates with the survival of breast cancer patients. These findings cast new light on a gene that has previously been described to be relevant during embryogenesis, but not carcinogenesis.

Original languageEnglish (US)
Pages (from-to)4273-4278
Number of pages6
JournalOncogene
Volume33
Issue number33
DOIs
StatePublished - Aug 14 2014
Externally publishedYes

Fingerprint

RNA Interference
Breast Neoplasms
Heterologous Transplantation
Neoplasms
Epithelial-Mesenchymal Transition
Neoplastic Stem Cells
Zinc Fingers
Genes
Embryonic Development
Carcinogenesis
Transcription Factors
Survival

Keywords

  • CDH1
  • EMT
  • In vivo RNAi screening
  • SALL1
  • shRNA screen
  • tumor suppressor

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Wolf, J., Müller-Decker, K., Flechtenmacher, C., Zhang, F., Shahmoradgoli, M., Mills, G., ... Boettcher, M. (2014). An in vivo RNAi screen identifies SALL1 as a tumor suppressor in human breast cancer with a role in CDH1 regulation. Oncogene, 33(33), 4273-4278. https://doi.org/10.1038/onc.2013.515

An in vivo RNAi screen identifies SALL1 as a tumor suppressor in human breast cancer with a role in CDH1 regulation. / Wolf, J.; Müller-Decker, K.; Flechtenmacher, C.; Zhang, F.; Shahmoradgoli, M.; Mills, Gordon; Hoheisel, J. D.; Boettcher, M.

In: Oncogene, Vol. 33, No. 33, 14.08.2014, p. 4273-4278.

Research output: Contribution to journalArticle

Wolf, J, Müller-Decker, K, Flechtenmacher, C, Zhang, F, Shahmoradgoli, M, Mills, G, Hoheisel, JD & Boettcher, M 2014, 'An in vivo RNAi screen identifies SALL1 as a tumor suppressor in human breast cancer with a role in CDH1 regulation', Oncogene, vol. 33, no. 33, pp. 4273-4278. https://doi.org/10.1038/onc.2013.515
Wolf, J. ; Müller-Decker, K. ; Flechtenmacher, C. ; Zhang, F. ; Shahmoradgoli, M. ; Mills, Gordon ; Hoheisel, J. D. ; Boettcher, M. / An in vivo RNAi screen identifies SALL1 as a tumor suppressor in human breast cancer with a role in CDH1 regulation. In: Oncogene. 2014 ; Vol. 33, No. 33. pp. 4273-4278.
@article{2334304b2e504ef19114fef71cbc3165,
title = "An in vivo RNAi screen identifies SALL1 as a tumor suppressor in human breast cancer with a role in CDH1 regulation",
abstract = "The gold standard for determining the tumorigenic potential of human cancer cells is a xenotransplantation into immunodeficient mice. Higher tumorigenicity of cells is associated with earlier tumor onset. Here, we used xenotransplantation to assess the tumorigenic potential of human breast cancer cells following RNA interference-mediated inhibition of over 5000 genes. We identify 16 candidate tumor suppressors, one of which is the zinc-finger transcription factor SALL1. Analyzing this particular molecule in more detail, we show that inhibition of SALL1 correlates with reduced levels of CDH1, an important contributor to epithelial-to-mesenchymal transition. Furthermore, SALL1 expression led to an increased migration and more than twice as many cells expressing a cancer stem cell signature. Also, SALL1 expression correlates with the survival of breast cancer patients. These findings cast new light on a gene that has previously been described to be relevant during embryogenesis, but not carcinogenesis.",
keywords = "CDH1, EMT, In vivo RNAi screening, SALL1, shRNA screen, tumor suppressor",
author = "J. Wolf and K. M{\"u}ller-Decker and C. Flechtenmacher and F. Zhang and M. Shahmoradgoli and Gordon Mills and Hoheisel, {J. D.} and M. Boettcher",
year = "2014",
month = "8",
day = "14",
doi = "10.1038/onc.2013.515",
language = "English (US)",
volume = "33",
pages = "4273--4278",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "33",

}

TY - JOUR

T1 - An in vivo RNAi screen identifies SALL1 as a tumor suppressor in human breast cancer with a role in CDH1 regulation

AU - Wolf, J.

AU - Müller-Decker, K.

AU - Flechtenmacher, C.

AU - Zhang, F.

AU - Shahmoradgoli, M.

AU - Mills, Gordon

AU - Hoheisel, J. D.

AU - Boettcher, M.

PY - 2014/8/14

Y1 - 2014/8/14

N2 - The gold standard for determining the tumorigenic potential of human cancer cells is a xenotransplantation into immunodeficient mice. Higher tumorigenicity of cells is associated with earlier tumor onset. Here, we used xenotransplantation to assess the tumorigenic potential of human breast cancer cells following RNA interference-mediated inhibition of over 5000 genes. We identify 16 candidate tumor suppressors, one of which is the zinc-finger transcription factor SALL1. Analyzing this particular molecule in more detail, we show that inhibition of SALL1 correlates with reduced levels of CDH1, an important contributor to epithelial-to-mesenchymal transition. Furthermore, SALL1 expression led to an increased migration and more than twice as many cells expressing a cancer stem cell signature. Also, SALL1 expression correlates with the survival of breast cancer patients. These findings cast new light on a gene that has previously been described to be relevant during embryogenesis, but not carcinogenesis.

AB - The gold standard for determining the tumorigenic potential of human cancer cells is a xenotransplantation into immunodeficient mice. Higher tumorigenicity of cells is associated with earlier tumor onset. Here, we used xenotransplantation to assess the tumorigenic potential of human breast cancer cells following RNA interference-mediated inhibition of over 5000 genes. We identify 16 candidate tumor suppressors, one of which is the zinc-finger transcription factor SALL1. Analyzing this particular molecule in more detail, we show that inhibition of SALL1 correlates with reduced levels of CDH1, an important contributor to epithelial-to-mesenchymal transition. Furthermore, SALL1 expression led to an increased migration and more than twice as many cells expressing a cancer stem cell signature. Also, SALL1 expression correlates with the survival of breast cancer patients. These findings cast new light on a gene that has previously been described to be relevant during embryogenesis, but not carcinogenesis.

KW - CDH1

KW - EMT

KW - In vivo RNAi screening

KW - SALL1

KW - shRNA screen

KW - tumor suppressor

UR - http://www.scopus.com/inward/record.url?scp=84906280767&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906280767&partnerID=8YFLogxK

U2 - 10.1038/onc.2013.515

DO - 10.1038/onc.2013.515

M3 - Article

C2 - 24292671

AN - SCOPUS:84906280767

VL - 33

SP - 4273

EP - 4278

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 33

ER -